Abstract
ProblemHow does hypoxia‐mediated downregulation of dual‐specificity phosphatase‐2 (DUSP2) promote the development of endometriotic lesions?Method of studyThe levels of IL‐6 and DUSP2 were assessed in eutopic stromal cells with DUSP2 knockdown or hypoxia treatment. Bromodeoxyuridine (BrdU) incorporation was applied for evaluating cell proliferation. The protein levels of DUSP2, cleaved caspase‐3, phosphorylated STAT3, and STAT3 were analyzed using immunoblot.ResultsThe genomewide analysis of cells with DUSP2 overexpression indicated IL‐6 regulates multiple pathways related to inflammation, proliferation, and apoptosis. DUSP2 overexpression significantly suppressed IL‐6 expression, while DUSP2 knockdown promoted IL‐6 expression. The hypoxia‐treated eutopic stromal cells expressed higher levels of IL‐6, recapitulating the elevated levels of IL‐6 in ectopic stromal cells. The treatment with IL‐6 elicited the phosphorylation of STAT3, mimicking the elevated levels of phosphorylated STAT3 in the ectopic stromal cells. The IL‐6‐treated eutopic stromal cells showed more BrdU incorporation and less cleaved caspase‐3, which can be reversed by STAT3 inhibitor.ConclusionHypoxia‐induced IL‐6 production in endometriotic lesions is mediated via downregulation of DUSP2, which causes aberrant activation of STAT3 signaling pathway and helps the endometriotic cells survive under the ectopic environment.
Topics

No keywords indexed for this article. Browse by subject →

References
43
[1]
Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries

Kelechi E. Nnoaham, Lone Hummelshoj, Premila Webster et al.

Fertility and Sterility 10.1016/j.fertnstert.2011.05.090
[2]
Endometriosis

Linda C Giudice, Lee C Kao

The Lancet 10.1016/s0140-6736(04)17403-5
[8]
IL-6 as a keystone cytokine in health and disease

Christopher A Hunter, Simon A Jones

Nature Immunology 10.1038/ni.3153
[28]
Beidler DR "Camptothecin induction of a time‐ and concentration‐dependent decrease of topoisomerase I and its implication in camptothecin activity" Mol Pharmacol (1995) 10.1016/s0026-895x(25)08586-4